title: Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea.
authors.forename: Matthew
authors.initials: M
authors.lastname: Olnes
authors.forename: Amy
authors.initials: A
authors.lastname: Chi
authors.forename: Carissa
authors.initials: C
authors.lastname: Haney
authors.forename: Rose
authors.initials: R
authors.lastname: May
authors.forename: Caterina
authors.initials: C
authors.lastname: Minniti
authors.forename: James
authors.initials: J
authors.lastname: Taylor
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Kato
mesh_terms: D000328:Adult; D000755:Anemia, Sickle Cell / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology; D000986:Antisickling Agents / Q000008:administration & dosage*; D001119:Arginase / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects*; D018572:Disease-Free Survival; D004452:Echocardiography / Q000379:methods; D005260:Female; D005319:Fetal Hemoglobin / Q000032:analysis; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage*; D008297:Male; D011651:Pulmonary Artery / Q000503:physiopathology*; D015996:Survival Rate; D014652:Vascular Diseases / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology
chemical_list: D000986:Antisickling Agents; D005319:Fetal Hemoglobin; D001119:Arginase; D006918:Hydroxyurea